negative regulation of type IV hypersensitivity

Any process that stops, prevents, or reduces the rate of type IV hypersensitivity, a type of inflammatory response.

The formation from simpler components of any of a group of naturally occurring, biologically active amines, such as norepinephrine, histamine, and serotonin, many of which act as neurotransmitters.

Stops, prevents or reduces the activity of metalloendopeptidases, enzymes that catalyze the hydrolysis of nonterminal peptide linkages in oligopeptides or polypeptides and contain a chelated metal ion at their active sites which is essential to their catalytic activity.

Catalysis of the reaction: GTP + IMP + L-aspartate = GDP + phosphate + N6-(1,2-dicarboxyethyl)-AMP.

Specialized membrane domains composed mainly of cholesterol and sphingolipids, and are relatively poor in polyunsaturated lipids such as glycerophospholipids. The formation of these membrane domains is promoted by the presence of cholesterol in the lipid bilayer: the rigid hexagonal rings of cholesterol can pack tightly against the saturated hydrocarbon chains of some membrane lipids, allowing these lipids to assemble into cohesive units floating in the mass of loosely packed polyunsaturated plasma membrane components.

The breakdown into simpler components of biogenic amines, any of a group of naturally occurring, biologically active amines, such as norepinephrine, histamine, and serotonin, many of which act as neurotransmitters.

Catalysis of the posttranscriptional addition of a guanyl residue to the 5' end of an RNA molecule.

The chemical reactions involving any of the compounds secreted by the thyroid gland, largely thyroxine and triiodothyronine.

The migration of immune cells (leukocytes) from the blood vessels into the surrounding tissue.

The breakdown into simpler components of any of the compounds secreted by the thyroid gland, largely thyroxine and triiodothyronine.

Catalysis of the transfer of a glycosyl group from a UDP-sugar to a small hydrophobic molecule.